Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 1;50(5):707-14.
doi: 10.1086/650458.

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus

Sophia Ng  1 , Benjamin J Cowling, Vicky J Fang, Kwok Hung Chan, Dennis K M Ip, Calvin K Y Cheng, Timothy M Uyeki, Peter M Houck, J S Malik Peiris, Gabriel M Leung
Affiliations

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus

Sophia Ng et al. Clin Infect Dis. .

Abstract

Background: Large clinical trials have demonstrated the therapeutic efficacy of oseltamivir against influenza. We assessed the indirect effectiveness of oseltamivir in reducing secondary household transmission in an incident cohort of influenza index patients and their household members.

Methods: We recruited index outpatients whose rapid test results were positive for influenza from February through September 2007 and January through September 2008. Household contacts were followed up for 7-10 days during 3-4 home visits to monitor symptoms. Nose and throat swabs were collected and tested for influenza by reverse-transcription polymerase chain reaction or viral culture.

Results: We followed up 384 index patients and their household contacts. Index patients who took oseltamivir within 24 h of symptom onset halved the time to symptom alleviation (adjusted acceleration factor, 0.56; 95% confidence interval [CI], 0.42-0.76). Oseltamivir treatment was not associated with statistically significant reduction in the duration of viral shedding. Household contacts of index patients who had taken oseltamivir within 24 h of onset had a nonstatistically significant lower risk of developing laboratory-confirmed infection (adjusted odds ratio, 0.54; 95% CI, 0.11-2.57) and a marginally statistically significant lower risk of clinical illness (adjusted odds ratio, 0.52; 95% CI, 0.25-1.08) compared with contacts of index patients who did not take oseltamivir.

Conclusions: Oseltamivir treatment is effective in reducing the duration of symptoms, but evidence of household reduction in transmission of influenza virus was inconclusive.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan Meier curves of time to resolution of (a) all symptoms (n=384), (b) fever (n=321), (c) respiratory symptoms (n=379) in index subjects with p-value of log-rank test.
Figure 2
Figure 2
Kaplan Meier curves of time to cessation of viral shedding in index subjects (n=392).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. Acute respiratory infections (Update February 2009) 2009. [cited 04/05/2009]; Available from: http://www.who.int/vaccine_research/diseases/ari/en/print.html.
    1. Centers for Disease Control and Prevention. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008–09 influenza season. 2008. 19/12/2008 [cited 04/05/2009]; Available from: http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279.
    1. Centers for Disease Control and Prevention. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. 2009. 06/06/2009 [cited 26/06/2009]; Available from: http://cdc.gov/h1n1flu/recommendations.htm.
    1. Jefferson TO, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthyadults. Cochrane Database Syst Rev. 2006;3:CD001265. - PubMed
    1. Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285(6):748–54. - PubMed

Publication types

MeSH terms